Alembic Pharma share jump 11% after company gets US FDA approval for Doxorubicin Hydrochloride Injection
The approval is for Alembic's Abbreviated New Drug Application (ANDA) for Doxorubicin Hydrochloride Liposome Injection in two strengths: 20 mg/10 mL and 50 mg/25 mL single-dose vials. This generic version is therapeutically equivalent to Doxil Liposome Injection, a product marketed by Baxter Healthcare.
Doxorubicin Hydrochloride Liposome is used in the treatment of ovarian cancer, AIDS-related Kaposi's sarcoma, and multiple myeloma.
According to IQVIA data, the approved product has an estimated market size of around $29 million for the 12-month period ending March 2025 in the U.S.
This approval adds to Alembic Pharma's growing presence in the U.S. generics market. With this, the company's tally now stands at 224 ANDA approvals, which includes 201 final approvals and 23 tentative approvals.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
11 minutes ago
- Business Upturn
Engineers India's shares drop fall nearly 3% as Q1 Net Profit declines 28.6% YoY
By Aditya Bhagchandani Published on August 14, 2025, 09:51 IST Shares of Engineers India fell 2.70% to Rs 195.80 in Thursday's early trade after the company reported a 28.6% year-on-year (YoY) decline in net profit for Q1 FY26 to Rs 65.4 crore, down from Rs 91.6 crore in the same period last year. The fall in share price led to a market capitalisation decline of about Rs 2,970 crore, bringing its current market cap to Rs 11,007 crore. The stock opened lower and moved within a range of Rs 195.53 to Rs 200.39 so far in the session, compared to the previous close of Rs 201.24. The year's trading range has been between Rs 142.20 and Rs 255.45. For the June quarter, Engineers India posted revenue of Rs 870 crore, marking a 39.4% increase from Rs 624 crore a year ago. EBITDA rose 40.3% to Rs 72.1 crore from Rs 51.4 crore last year, while operating margins were steady at 8.3% versus 8.2% in Q1 FY25. Engineers India Limited, established in 1965, operates as a public sector industrial technology, engineering consultancy, and technology licensing company. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Business Upturn
11 minutes ago
- Business Upturn
Deepak Nitrite shares drop over 4% as Q1 revenue falls 12.8% YoY to Rs 1,890 crore, net profit down 44.6% YoY
By Aman Shukla Published on August 14, 2025, 09:55 IST Shares of Deepak Nitrite saw a sharp decline of over 4% in early morning trading after the company reported its Q1 results for the financial year. Investors reacted to the disappointing performance, which showed a notable drop in both revenue and profitability compared to the same period last year. Deepak Nitrite reported revenue of Rs 1,890 crore, down 12.8% from Rs 2,167 crore in the previous year. The company's EBITDA fell sharply by 38.7% to Rs 190 crore versus Rs 309 crore last year, with the margin declining to 10% from 14.3%. Net profit also took a significant hit, dropping 44.6% to Rs 112 crore from Rs 203 crore in Q1 FY24. The stock opened at Rs 1,800 and traded in a range of Rs 1,775 to Rs 1,830 during the morning session. This comes after the previous close of Rs 1,873.30. The 52-week high for Deepak Nitrite stands at Rs 3,093.75, while the 52-week low is Rs 1,775. As of 9:53 AM, the shares were trading 4.06% lower at Rs 1,797.30. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
11 minutes ago
- Business Upturn
Texmaco Rail shares drop over 3% as Q1 revenue falls 16.3% YoY to Rs 911 crore, net profit down 49.9% YoY
By Aman Shukla Published on August 14, 2025, 09:46 IST Texmaco Rail shares slipped over 3% in early trade following the announcement of its Q1 results, reflecting a challenging start to the fiscal year. As of 9:45 AM, the shares were trading 3.23% lower at Rs 136.41. The company reported a consolidated revenue of Rs 911 crore for Q1, down 16.3% from Rs 1,088 crore in the same period last year. EBITDA fell sharply by 33.7% to Rs 70.9 crore compared to Rs 107 crore in Q1 FY25, with margins contracting to 7.8% from 9.8% year-on-year. Net profit also took a hit, declining 49.9% to Rs 30 crore versus Rs 59.8 crore in the corresponding quarter last year. Texmaco Rail shares opened at ₹137.00 today and witnessed a drop, with the stock trading between ₹135.00 and ₹138.06 during the day. The previous close for the stock was ₹140.97, indicating a slight downward trend in early trades. Over the past 52 weeks, Texmaco Rail has seen a low of ₹119.06 and a high of ₹262.95. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
